baber/WOPTO huggingface dataset:
Patent WO-2020242886-A1 (WO)
Title: Doherty amplifier circuit with integrated harmonic termination
Inventor: KIM JANGHEON
IPC: H03F3/217
Filed: 2020-05-21
Abstract: In a Doherty amplifier (30), outputs of first or main (18a) and second or peak (18b) transistors are connected by a combined impedance inverter and harmonic termination circuit (36). The harmonic termination circuit (40) incorporates a predetermined part of the impedance inverter (38), and provides a harmonic load impedance at a targeted harmonic frequency (e.g., the second harmonic). Control of the amplitude and phase of the harmonic load impedance facilitates shaping of the drain current and voltage waveforms to maximize gain and efficiency, while maintaining a good load modulation at a fundamental frequency. Particularly for Group III nitride semiconductors, such as GaN, both harmonic control (26) and output impedance matching circuits (20) may be eliminated from the outputs of each transistor (18). The combined impedance inverter and harmonic termination circuit (36) reduces the amplifier circuit (30) footprint, for high integration and low power consumption.
Patent WO-2020247490-A1 (WO)
Inventor: LANGERVELD ANNA
IPC: A61P25/36
Filed: 2020-06-03
Abstract: The present disclosure relates to methods for assessing whether a subject is genetically predisposed to the risk of opioid addiction including opioid relapse or opioid use disorder. The method comprises: (1) performing an allelic analysis on the biological sample to determine the presence of a plurality of pre-determined alleles; (2) assigning a count for each of the alleles in the plurality of pre-determined alleles that was present in the biological sample; (3) determining a risk score based upon a total count, wherein the risk score identifies a severity of the genetic predisposition to opioid addiction or relapse risk; and (4) administering a medical assisted treatment procedure based on the risk score identified in the subject.
Patent WO-2021061205-A1 (WO)
Title: Interbody lattice structure
Inventor: ROTH NOAH
IPC: A61F2/30
Filed: 2020-06-05
Abstract: An orthopedic implant which generally includes a frame structure and a porous structure. Both the frame and porous structure at least partially define at least six surfaces which make a three-dimensional profile of the implant. The porous structure is positioned at least partially within the three-dimensional profile.
Patent WO-2020257131-A1 (WO)
Inventor: AGARWAL SHIVAM
IPC: G01N21/86
Filed: 2020-06-16
Abstract: Using data about the geometry of the wafer, the geometry of the wafer is measured along at least three diameters originating at different points along a circumference of the wafer. A characterization of the geometry of the wafer is determined using the three diameters. A probability of wafer clamping failure for the wafer can be determined based on the characterization.
Patent WO-2020263697-A1 (WO)
Inventor: SUBRAMANIAM BALA
IPC: C07C31/18
Filed: 2020-06-19
Abstract: Methods for gas-phase deoxygenation of a bio-oil are provided. In embodiments, such a method comprises exposing a bio-oil vapor comprising hydrocarbon compounds having oxygenated aromatic groups, to hydrogen gas in the presence of catalyst under conditions to induce deoxygenation of the oxygenated aromatic groups to provide a deoxygenated aromatic species, wherein the catalyst is a transition metal-incorporated mesoporous silicate having platinum deposited thereon and the transition metal is selected from Nb, W, Zr, and combinations thereof. The transition metal-incorporated mesoporous silicate catalysts are also provided.
Patent WO-2020263734-A1 (WO)
Title: Erwinia isolates and uses thereof
Inventor: YOUNG HUGH
IPC: A01N63/20
Filed: 2020-06-22
Abstract: The present disclosure provides fungicidal Erwinia and Pseudomonas strains useful for protecting plants and enhancing crop yield, as well as cultures and inoculant compositions comprising the isolated strains, cellular extracts derived from the isolated strains, and cell-free filtrates derived from cultures of the isolated strains.
Patent WO-2021016124-A1 (WO)
Title: Fuel flow control device for delivery of fuel to a fuel tank
Inventor: SCHMIDT BRENNAN
IPC: E21B41/00
Filed: 2020-07-17
Abstract: An electric fuel flow control device for delivery of fuel to fuel tank use with oil and gas equipment, such as fueling systems for frac pumps. The electric fuel flow control device includes a battery, control circuitry, an enclosure(102) that encloses the control circuity, and includes an electric fluid sensor (104), a valve (106), a beacon light (116), a status light (118), a button (120), an adapter cap (122) enabling connection to a fuel tank, and a mandrel (124). The electric fuel flow control device may be used as a primary fuel flow control device or a backup fuel flow control device.
Patent WO-2021096573-A1 (WO)
Title: Programmable device having hardened circuits for predetermined digital signal processing functionality
Inventor: MCGRATH JOHN
IPC: H03K19/1776
Filed: 2020-08-11
Abstract: An example programmable device includes a configuration memory configured to store configuration data; a programmable logic having a configurable functionality based on the configuration data in the configuration memory; a signal conversion circuit; a digital processing circuit; an endpoint circuit coupled to the signal conversion circuit through the digital processing circuit; wherein the digital processing circuit includes a first one or more digital processing functions implemented as hardened circuits each having a predetermined functionality, and a second one or more processing functions implemented by the configurable functionality of the programmable logic.
Patent WO-2021050254-A1 (WO)
Inventor: WONG LIK
IPC: G06F16/2458
Filed: 2020-08-24
Abstract: L'invention concerne des techniques de traitement d'une commande de base de données dans une base de données partitionnée. Le traitement de la commande de base de données peut comprendre la génération ou autrement l'accès à une expression de clé de fragment, et l'évaluation de l'expression de clé de fragment pour identifier un ou plusieurs fragments cibles qui contiennent des données utilisées pour exécuter la commande de base de données.
Patent WO-2021041838-A1 (WO)
Title: Prediction based delivering or guiding of therapy for diabetes
Inventor: WEYDT PATRICK E
IPC: G16H40/60
Filed: 2020-08-28
Abstract: An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.
Patent WO-2021046059-A1 (WO)
Title: System and method for computed laminography x-ray fluorescence imaging
Inventor: YUN WENBING
IPC: G01N23/2204
Filed: 2020-09-01
Abstract: A system and a method use x‑ray fluorescence to analyze a specimen by illuminating a specimen with an incident x‑ray beam having a near-grazing incident angle relative to a surface of the specimen and while the specimen has different rotational orientations relative to the incident x‑ray beam. Fluorescence x‑rays generated by the specimen in response to the incident x‑ray beam are collected while the specimen has the different rotational orientations.
Patent WO-2021055230-A1 (WO)
Title: Optical systems with low resolution peripheral displays
IPC: G02B27/01
Filed: 2020-09-10
Abstract: An electronic device may include an optical combiner with a waveguide. The waveguide may have an output coupler that directs high resolution light towards an eye box within a field of view. Peripheral light sources may provide low resolution peripheral light to the eye box about a periphery of the field of view. The peripheral light sources may be mounted to a frame for the waveguide, to an additional substrate mounted to the frame and overlapping the waveguide, in a low resolution projector that projects the peripheral light towards reflective structures in the additional substrate, or in a display module that produces the high resolution light. The optical combiner may overlay real world light with the high resolution light and the low resolution peripheral light.
Patent WO-2021055636-A1 (WO)
Title: Therapeutic uses and methods of delivery of viscous compositions during pre and post surgical periods, for treatment of responsive diseases of the ear, nose, and throat
Inventor: REITZ RUSSELL
IPC: A61K9/06
Filed: 2020-09-17
Abstract: A medication or combination of medications for the treatment of a disease involving the sinuses is incorporated into a sterile medical gel. The viscosity of the gel or the adhesion of the gel to the patient's sinus cavity allows the gel to be maintained in the cavity for a sufficient length of time for treatment of the affected area, thereby reducing the amount of wasted medication that would otherwise result from other topical methods. In one embodiment, the medicated gel comprises a sterile viscous gel having a viscosity sufficient to be maintained within a paranasal sinus cavity after insertion, and a medication dispersed in the sterile viscous gel.
Patent WO-2022060367-A1 (WO)
Title: Privacy data switch
Inventor: LI KUAN-LIN
IPC: G02B27/01
Filed: 2020-09-21
Abstract: Various examples described herein relate to a head mountable device (HMD) which comprises an input device to receive captured user data, a connection interface to exchange the user data with a host device, a privacy data switch to route the user data between the input device and the connection interface in the HMD, and a controller. The controller determines whether the user data is restricted data, directs the privacy data switch to block the exchange of the user data when it is determined that the user data is restricted data, and directs the switch to allow the exchange of the user data when it is determined that the user data is not restricted data.
Patent WO-2021061924-A1 (WO)
Title: Systems and methods for updating three-dimensional medical images using two-dimensional information
Inventor: FINLEY ERIC
IPC: G06T7/70
Filed: 2020-09-24
Abstract: Disclosed herein are systems, methods, and media for updating preoperative 3D dataset using at least two 2D intraoperative images to reflect changes in anatomical features caused by patient movement.
Patent WO-2021071982-A1 (WO)
Title: Compounds for modulating splicing
Inventor: LUZZIO Michael
IPC: A61K31/185
Filed: 2020-10-07
Abstract: Described herein are agents that modify splicing of pre-mRNA and methods of making and using the same.
Patent WO-2021080812-A1 (WO)
Title: A product release system, method and device having a customizable prepurchase function
Inventor: COKER MARK CHARLES
IPC: G06Q30/00
Filed: 2020-10-13
Abstract: A product release system, method and device that enables product controllers to generate product listings for one or more products as well as one or more customized prepurchase events for each of the products. The product release system, method and device then executes the prepurchase events according to one or more pricing, timing and permission conditions specified for each of the prepurchase events, facilitates the purchasing of the products during the prepurchase events and notifies the product controllers of the results of the prepurchase events.
Patent WO-2021097192-A1 (WO)
Title: Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
Inventor: SCHUCH RAYMOND
IPC: C07K14/01
Filed: 2020-11-13
Abstract: The present disclosure is directed to lysin-AMP polypeptide constructs, isolated lysin polypeptides, and pharmaceutical compositions comprising the isolated polypeptides and/or lysin-AMP polypeptide constructs. Methods of using the lysin-AMP polypeptide constructs, isolated lysin polypeptides and pharmaceutical compositions are also herein provided, including methods of treating a bacterial infection of an organ or tissue in which pulmonary surfactant is present or Gram-negative bacterial infections that are associated with a biofilm. In addition, isolated polynucleotides encoding the lysin-AMP polypeptide constructs and isolated lysin polypeptides are disclosed herein.
Patent WO-2021097331-A1 (WO)
Title: System and method for collection of fit data related to a selected mask
Inventor: PEAKE GREGORY
IPC: G16H10/60
Filed: 2020-11-13
Abstract: A system and method to collect feedback data from a patient wearing an interface such as a mask when using a respiratory pressure therapy device such as a CPAP device. The system includes a storage device including a facial image of the patient. An interface in communication with the respiratory pressure therapy device collect operational data from when the patient uses the interface. A patient interface collects subjective patient input data from the patient in relation to the patient interface. An analysis module correlates a characteristic of the interface with the facial image data, operational data and subjective patient input data.
Patent WO-2021138496-A1 (WO)
Title: Two-piece clip applier jaw assembly and method of manufacture
Inventor: SANDSTROM ALEX
IPC: A61B17/04
Filed: 2020-12-30
Abstract: A clip applier jaw assembly and processes for manufacturing a clip applier jaw are described. The clip applier jaw assembly includes a first jaw and a second jaw joined to the first jaw. The first and second jaws are independently formed and subsequently joined. A progressive stamping process can be used to form each of the first and second jaws by cutting a compound cut in a sheet of material, deburring the cut jaw blank with an edge coining process, and coining a clip groove in the jaw blank. A second jaw can be formed using the same process in a die configured to produce a mirror image of the first jaw. The first and second jaws can be joined by a welding process.
Patent WO-2021134088-A1 (WO)
Inventor: AUNE AMUND
IPC: G06F13/42
Filed: 2020-09-03
Abstract: A serial communication link receiver-transmitter with autonomous transmission error detection is described, and a communication peripherals including the same. Transmit data at a transmitter and transmitted data output by the transmitter and received by the receiver are observed by an error detector configured to generate an error indication in response to difference between the transmit data and corresponding observed transmit data of a transmitted data frame. If a difference is detected a transmit error indicator is asserted.
Patent WO-2021142192-A1 (WO)
Title: Microparticle-based enzyme systems for selective removal of target molecules
Inventor: MOSER FELIX
IPC: A61K9/127
Filed: 2021-01-08
Abstract: The present disclosure provides compositions of microparticles and uses thereof for removing toxic or undesirable molecules from an environment, e.g. the blood of a subject. The microparticles can be liposomes. In one embodiment, the aqueous phase of the liposomes contains (i) a system of generating NAD +  from NADH, and (ii) one or more enzymes that are involved in one or more NAD + - dependent reactions that remove the toxic or undesirable molecules from the environment. In one embodiment, the liposomes contain NADH oxidase, alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) to remove ethanol from the blood of a subject.
Patent WO-2021158874-A1 (WO)
Title: Light-emitting device with metal inlay and bottom contacts
Inventor: HIN TZE YANG
IPC: H01L33/62
Filed: 2021-02-05
Abstract: Light-emitting devices are described herein. A light-emitting device includes a hybridized device having a top surface and a bottom surface and a packaging substrate comprising a metal inlay in an opening in the packaging substrate and conductive vias. The metal inlay is thermally coupled to the bottom surface of the hybridized device. Conductive contacts are disposed on a bottom surface of the packaging substrate, each electrically coupled to one of the plurality of conductive vias. Conductive connectors electrically coupled between the top surface of the hybridized device and the top surface of the packaging substrate. Each of the conductive connectors is electrically coupled to a respective one of the conductive contacts on the bottom surface of the packaging substrate by a respective on of the conductive vias.
Patent WO-2021163094-A1 (WO)
Title: Chemical recycling of processed mixed plastic waste streams
Inventor: DEBRUIN BRUCE
IPC: B09B3/00
Filed: 2021-02-10
Abstract: Chemical recycling facilities for processing mixed plastic waste are provided herein. Such facilities have the capability of processing mixed plastic waste streams and utilize a variety of recycling facilities, such as, for example, solvolysis facility, a pyrolysis facility, a cracker facility, a partial oxidation gasification facility, an energy generation/energy production facility, and a solidification facility. Streams from one or more of these individual facilities may be used as feed to one or more of the other facilities, thereby maximizing recovery of valuable chemical components and minimizing unusable waste streams.
Patent WO-2021173648-A1 (WO)
Inventor: STASTKA JERRY J
IPC: A61F2/962
Filed: 2021-02-24
Abstract: A removable constraining device, systems, and methods for constraining and delivering an expandable member is disclosed. The removable constraining device includes a plurality of strands interlocking to form a cover body having a length, the plurality of strands in the form of a warp knit, and the plurality of strands including at least a first set of strands and a second set of strands. The removable constraining device also includes a first release zone defined by the first set of strands of the cover body along the length of the cover body and a second release zone defined by the seconds set of strands of the cover body, the second release zone being coextensive with the first release zone along at least a portion of the length of the cover body. The removable constraining device may be released at release zones by substantially simultaneously tensioning deployment lines.
Patent WO-2021178416-A1 (WO)
Inventor: HUTCHINS JEFF T
IPC: A61K39/39
Filed: 2021-03-02
Abstract: The present invention provides an expression vector, host cells, methods and kits for the treatment or prevention of a coronavirus infection in a subject.
Patent WO-2021247112-A1 (WO)
Inventor: DAVIS RICHARD C
IPC: E21B7/06
Filed: 2021-03-05
Abstract: A sidetrack assembly for forming a lateral wellbore includes a cutting device having a body having a passage, and a mill head configured to connect to the body so that an interior of the mill head and the body form a pressure chamber in fluid communication with the outlet passage. The mill head includes a first port in fluid communication with the pressure chamber, a second port in fluid communication with the pressure chamber, and a blade arranged on a face of the mill head. A whipstock connected to the cutting device includes a tubing having a first end removably inserted in the first port and the passage and a second end connectable to a downhole tool, an inclined surface for guiding the mill at a non-zero angle relative to a central axis of an existing wellbore, and an attachment section removably connecting the cutting device and the whipstock.
Patent WO-2021188873-A1 (WO)
Title: Systems and methods for enhanced reactive power management in a hybrid environment
Inventor: PAGAN KAREN EMANUELLE HERNANDEZ
IPC: H02J3/48
Filed: 2021-03-19
Abstract: A system for controlling a hybrid power generation plant is provided. The system is programmed to receive current conditions at the plurality of power generating assets including a first asset type and a second asset type, determine a forecast for a period of time based at least in part on the current conditions, determine that a first asset of the first asset type of the plurality of power generating assets has an available uprate margin for production of a first amount of active power, determine that a second asset of the second asset type of the plurality of power generating assets has capacity to generate a second amount of reactive power, instruct the first asset to reduce production of reactive power by the second amount and increase production of active power by the first amount, and instruct the second asset to increase production of reactive power by the second amount.
Patent WO-2021202209-A1 (WO)
Title: Communication routing based on user characteristics and behavior
Inventor: SCOTT BRANDON
IPC: G06F15/16
Filed: 2021-03-24
Abstract: An enhanced routing system determines a service provider best suited to fulfill a user's request to interact and establishes a communication session between the user's client device and a device of the service provider. The enhanced routing system may use user characteristics and behavior to select the service provider. For example, the enhanced routing system receives a request to connect to a customer service system from a user who has recently started a new job and has been accessing a banking application on his mobile phone. The enhanced routing system may determine that a payroll service provider is best suited to fulfill the user's request. For example, the enhanced routing system uses a machine learning model that has been trained on previously fulfilled requests. In this way, the enhanced routing system improves upon systems that continuously prompt the user for information by selecting a service provider without overburdening the user.
Patent WO-2021202437-A1 (WO)
Title: Methods and pharmaceutical compositions of thromboxane a2 receptor antagonist for the treatment of covid-19
Inventor: OGLETREE MARTIN
IPC: A61K31/559
Filed: 2021-03-30
Abstract: The present invention is related to the use of thromboxane A2 receptor antagonists (e.g., 3-[2-[[(1S,2R,3S,4R)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid (Ifetroban), or one, or a mixture of more than one pharmaceutically acceptable salts thereof) in the treatment of SARS-CoV-2 infection in humans, and pharmaceutical compositions for the same comprising thromboxane A2 receptor antagonists (e.g., ifetroban) in an effective amount to treat and/or prevent conditions resulting from such infection.
Patent WO-2021202627-A1 (WO)
Title: Process for conversion of bis(hydroxyethylethoxy)-urea to dga
Inventor: HOLUB PATRICK E
IPC: B01D53/62
Filed: 2021-03-31
Abstract: A reclaimer system and methods for using said reclaimer system to reclaim one or more amine agents from a fluid containing one or more degradation products that have been formed from the reaction of one or more acid gas components with the one or more amine agents.
Patent WO-2021207225-A1 (WO)
Title: Multi-mode eye-tracking with independently operable illuminators
Inventor: CHAPPELL ROBERT C
IPC: G06F3/01
Filed: 2021-04-06
Abstract: A multi-mode eye-tracking system allows independent control of a set of illuminators while providing accurate calculations of both corneal reflections and pupil centers. One illumination mode includes alternating back and forth between a pair of illuminators during successive time segments, then activating both illuminators after a predetermined time interval. One eye-tracking mode includes alternating back and forth between a pair of illuminators during successive time segments, but selecting a single illuminator for activation during successive time segments in the event that a previous computation was unsatisfactory for a given illuminator. One illumination mode includes activating a single illuminator based on the lateral position of the gaze point on the display.